MagForce (MF6) Stock Overview

Develops advanced nanomedicine for cancer therapies. More details

MF6 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Latest financial reports are more than a year old

Does not have a meaningful market cap (€92K)

Highly volatile share price over the past 3 months compared to the German market

MF6 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW446,702 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

446,702 investors already sharing narratives

View all narratives

MagForce AG Competitors

Price History & Performance

Summary of share price highs, lows and changes for MagForce
Historical stock prices
Current Share Price	€0.003
52 Week High	€0.018
52 Week Low	€0.001
Beta	0
1 Month Change	-14.29%
3 Month Change	0%
1 Year Change	0%
3 Year Change	7.14%
5 Year Change	n/a
Change since IPO	-53.13%

Recent updates

Shareholder Returns

	MF6	DE Medical Equipment	DE Market
7D	0%	-0.8%	-2.3%
1Y	0%	-18.4%	4.8%

Return vs Industry: MF6 exceeded the German Medical Equipment industry which returned -18.4% over the past year.

Return vs Market: MF6 underperformed the German Market which returned 4.8% over the past year.

Price Volatility

Is MF6's price volatile compared to industry and market?
MF6 volatility
MF6 Average Weekly Movement	14.8%
Medical Equipment Industry Average Movement	5.3%
Market Average Movement	5.0%
10% most volatile stocks in DE Market	11.9%
10% least volatile stocks in DE Market	2.5%

Stable Share Price: MF6's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: MF6's weekly volatility has decreased from 35% to 15% over the past year, but is still higher than 75% of German stocks.

About the Company

Founded	Employees	CEO	Website
1997	n/a	Ben Lipps	www.magforce.de/

MagForce AG develops advanced nanomedicine for cancer therapies. It offers NanoTherm therapy system, a combination of medical devices for the treatment of solid brain tumors; NanoPlan, a software that stimulates the temperature distribution in the treatment area; NanoTherm, a magnetic ferrofluid; and NanoActivator, a magnetic field generator. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany.

MagForce AG Fundamentals Summary

How do MagForce's earnings and revenue compare to its market cap?
MF6 fundamental statistics
Market cap	€91.72k
Earnings (TTM)	-€10.57m
Revenue (TTM)	€1.08m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is MF6 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MF6 income statement (TTM)
Revenue	€1.08m
Cost of Revenue	€918.75k
Gross Profit	€158.39k
Other Expenses	€10.73m
Earnings	-€10.57m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did MF6 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/09/16 20:46
End of Day Share Price	2026/09/16 00:00
Earnings	2021/12/31
Annual Earnings	2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MagForce AG is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Thomas Jones	Berenberg
Susie Jana	Edison Investment Research
Cosmin Filker	GBC AG

MagForce AGBST:MF6 Stock Report